1. Home
  2. RBOT vs FBRX Comparison

RBOT vs FBRX Comparison

Compare RBOT & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RBOT
  • FBRX
  • Stock Information
  • Founded
  • RBOT 2014
  • FBRX N/A
  • Country
  • RBOT United States
  • FBRX United States
  • Employees
  • RBOT N/A
  • FBRX N/A
  • Industry
  • RBOT Medical Specialities
  • FBRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • RBOT Health Care
  • FBRX Health Care
  • Exchange
  • RBOT Nasdaq
  • FBRX Nasdaq
  • Market Cap
  • RBOT 33.9M
  • FBRX 35.3M
  • IPO Year
  • RBOT N/A
  • FBRX N/A
  • Fundamental
  • Price
  • RBOT $5.39
  • FBRX $7.34
  • Analyst Decision
  • RBOT Hold
  • FBRX Strong Buy
  • Analyst Count
  • RBOT 2
  • FBRX 3
  • Target Price
  • RBOT $9.25
  • FBRX $80.50
  • AVG Volume (30 Days)
  • RBOT 20.7K
  • FBRX 50.8K
  • Earning Date
  • RBOT 04-28-2025
  • FBRX 05-12-2025
  • Dividend Yield
  • RBOT N/A
  • FBRX N/A
  • EPS Growth
  • RBOT N/A
  • FBRX N/A
  • EPS
  • RBOT N/A
  • FBRX N/A
  • Revenue
  • RBOT N/A
  • FBRX N/A
  • Revenue This Year
  • RBOT N/A
  • FBRX N/A
  • Revenue Next Year
  • RBOT N/A
  • FBRX N/A
  • P/E Ratio
  • RBOT N/A
  • FBRX N/A
  • Revenue Growth
  • RBOT N/A
  • FBRX N/A
  • 52 Week Low
  • RBOT $4.27
  • FBRX $4.11
  • 52 Week High
  • RBOT $19.00
  • FBRX $28.68
  • Technical
  • Relative Strength Index (RSI)
  • RBOT 33.03
  • FBRX 52.55
  • Support Level
  • RBOT $5.07
  • FBRX $5.25
  • Resistance Level
  • RBOT $5.95
  • FBRX $6.43
  • Average True Range (ATR)
  • RBOT 0.57
  • FBRX 0.82
  • MACD
  • RBOT 0.15
  • FBRX 0.21
  • Stochastic Oscillator
  • RBOT 22.54
  • FBRX 57.71

About RBOT Vicarious Surgical Inc.

Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.

About FBRX Forte Biosciences Inc.

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).

Share on Social Networks: